» Articles » PMID: 3841305

Antithyroglobulin Monoclonal and Autoantibodies Cross-react with an Orbital Connective Tissue Membrane Antigen: a Possible Mechanism for the Association of Ophthalmopathy with Autoimmune Thyroid Disorders

Overview
Date 1985 Nov 1
PMID 3841305
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

The possibility that Graves' ophthalmopathy and autoimmune thyroid disorders may be associated because of autoimmune reactions against antigens shared between human orbital and thyroid tissues was investigated using anti-thyroglobulin (Tg) monoclonal and autoantibodies. Eleven of 16 mouse monoclonal antibodies (MCAB) tested reacted, in an enzyme-linked immunosorbent assay (ELISA), with an antigen in human orbital connective tissue membranes (OCTmem), but not with the OCT soluble fraction, or with membrane or soluble fractions of human eye muscle, lacrimal gland or skin connective tissue. The anti-OCTmem activity was absorbed by OCTmem and Tg, but not by liver membranes or bovine serum albumin (BSA). In preliminary studies four out of 113 human MCAB against thyroid or orbital tissue antigens showed reactivity restricted to Tg and OCTmem. Sera from approximately 50% of patients with autoimmune thyroid disorders, with or without ophthalmopathy, also reacted with OCTmem. The autoantibody activity correlated closely with serum titres of antithyroglobulin but not with the presence, duration, or severity of the eye disease. The OCTmem reactivity was absorbed by Tg, thyroid membranes, and OCTmem but not liver membranes, membranes prepared from other orbital tissues, or BSA. The OCTmem-Tg shared antigen site appeared not to be native thyroglobulin since, (i) MCAB and serum autoantibodies did not react with the cytosol fraction of OCT, and (ii) because the membrane antigen was not solubilizable. Because not all patients with ophthalmopathy have detectable anti-Tg antibodies and, conversely, because not all patients with detectable anti-Tg antibodies develop ophthalmopathy it is unlikely that autoimmunity against a OCTmem-Tg shared antigen is the primary mechanism of Graves' ophthalmopathy, although this possibility has not been excluded. On the other hand the reaction of anti-Tg autoantibodies with OCT membranes may be a model for other autoimmune reactions against other thyroid-orbital tissue-shared antigens. While the pathogenesis of Graves' ophthalmopathy is likely to be multifactorial, humoral and cellular reactions against primary orbital antigens, thyroid-orbitol tissue shared antigens, or both, are likely to play important roles.

Citing Articles

Effect of thyroid hormone status on complete blood cell count-derived inflammatory biomarkers in patients with moderate-to-severe Graves' ophthalmopathy.

Yuksel N, Saritas O, Yuksel E Int Ophthalmol. 2023; 43(9):3355-3362.

PMID: 37209204 DOI: 10.1007/s10792-023-02742-x.


Does autoimmunity against thyroglobulin play a role in the pathogenesis of Graves' ophthalmopathy: a review.

Shanmuganathan T, Girgis C, Lahooti H, Champion B, Wall J Clin Ophthalmol. 2015; 9:2271-6.

PMID: 26664042 PMC: 4671807. DOI: 10.2147/OPTH.S88444.


Role of thyroglobulin in the pathogenesis of Graves' ophthalmopathy: the hypothesis of Kriss revisited.

Marino M, Chiovato L, Lisi S, Altea M, Marcocci C, Pinchera A J Endocrinol Invest. 2004; 27(3):230-6.

PMID: 15164998 DOI: 10.1007/BF03345271.


Cross-reactive antibodies in the serum of balb/c mice immunized with thyroid or eye muscle membranes.

Wall J, Triller H, Chung F, Tsao M, BOUCHER A, Rodien P J Endocrinol Invest. 1994; 17(2):105-12.

PMID: 7516357 DOI: 10.1007/BF03347694.


A study of human-human hybridomas from patients with autoimmune thyroid disease.

De Bernardo E, Davies T J Clin Immunol. 1987; 7(1):71-7.

PMID: 3558736 DOI: 10.1007/BF00915428.


References
1.
KROLL A, Kuwabara T . Dysthyroid ocular myopathy. Anatomy, histology, and electron microscopy. Arch Ophthalmol. 1966; 76(2):244-7. DOI: 10.1001/archopht.1966.03850010246017. View

2.
Bogner U, Schleusener H, Wall J . Antibody-dependent cell mediated cytotoxicity against human thyroid cells in Hashimoto's thyroiditis but not Graves' disease. J Clin Endocrinol Metab. 1984; 59(4):734-8. DOI: 10.1210/jcem-59-4-734. View

3.
Sisson J, Kothary P, Kirchick H . The effects of lymphocytes, sera, and long-acting thyroid stimulator from patients with Graves' disease on retrobulbar fibroblasts. J Clin Endocrinol Metab. 1973; 37(1):17-24. DOI: 10.1210/jcem-37-1-17. View

4.
Kohler G, Milstein C . Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975; 256(5517):495-7. DOI: 10.1038/256495a0. View

5.
WERNER S . Modification of the classification of the eye changes of Graves' disease: recommendations of the Ad Hoc Committee of the American Thyroid Association. J Clin Endocrinol Metab. 1977; 44(1):203-4. DOI: 10.1210/jcem-44-1-203. View